Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus
Autoimmunity Reviews · 2023-02 · 22 (2) · 103262
DOI: 10.1016/j.autrev.2022.103262 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Autoimmunity Reviews, 2023-02. Verfasst von Valeria Erazo-Martínez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Fundación Valle del Lili, Centro de Investigaciones Clínicas, Cra 98 No. 18-49, Cali 760032, Colombia. Hauptthemen laut MEDLINE: Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Systemic. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 80 Literaturangaben.
Abstract (Originalsprache)
Cutaneous lupus erythematosus (CLE) is a common disease that may appear as a separate entity from systemic lupus erythematosus (SLE), precede SLE development, or occur as a manifestation of this systemic disease. It has a complex pathophysiology that involves genetic, environmental, and immune-mediated factors creating a self-amplification pro-inflammatory cycle. CLE is characterized by prominent type I interferons (IFNs) inflammation which are considered as the first precursors of the inflammatory cascade generated within the pathophysiology of CLE. TNF-α enhances the production of antibodies through the activation of B cells, and favors the expression of surface nuclear antigens on keratinocytes. UV light exposure favors keratinocyte apoptosis or necroptosis, which results in the release of multiple proinflammatory cytokines, including IL-6, IL-1α, IL-1β, TNF-α, IFNs, and CXCL10. Serum levels of IL-17 are elevated in patients with ACLE, SCLE, and DLE. Evidence suggests IL-22 plays a role primarily in tissue repair rather than in inflammation. High expression of BAFF and its receptors have been found in lesioned keratinocytes of patients with CLE, and patients with CLE have lower serum levels of the regulatory cytokines TGF-β and IL-10. The chemokines CXCL9 and CXCL10 (CXCR3 ligands) have an increased expression among these patients, and their expression is correlated with IFNs levels. CXCR3 ligands recruit cytotoxic type I cells through this receptor, further supporting the death of keratinocytes via necroptosis with the subsequent release of eNAs perpetuating the inflammatory cycle. Interface dermatitis is characterized by the presence of CXCR3-positive lymphocytes. This review describes the leading cytokines and chemokines present in the circulation and skin that play a fundamental role in the pathogenesis of CLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fundación Valle del Lili, Centro de Investigaciones Clínicas, Cra 98 No. 18-49, Cali 760032, Colombia.
- Southern Illinois University School of Medicine, Department of Medical Microbiology, Immunology and Cell Biology, Springfield, IL, USA.
- Universidad Icesi, CIRAT: Centro de Investigación en Reumatología, Autoinmunidad y Medicina Traslacional, Calle 18 No. 122-135, Cali, Colombia; Fundación Valle del Lili, Unidad de Reumatología, Cra 98 No. 18-49, Cali 76…
Zitieren
APA
Erazo-Martínez, V., Tobón, G. J., & Cañas, C. A. (2023). Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus. Autoimmunity Reviews, 22(2), 103262. https://doi.org/10.1016/j.autrev.2022.103262
Vancouver
Erazo-Martínez V, Tobón GJ, Cañas CA. Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus. Autoimmunity Reviews. 2023;22(2):103262. doi:10.1016/j.autrev.2022.103262
BibTeX
@article{ErazoMartnez2023,
author = {Erazo-Martínez, Valeria and Tobón, Gabriel J and Cañas, Carlos A},
title = {Circulating and skin biopsy-present cytokines related to the pathogenesis of cutaneous lupus erythematosus},
journal = {Autoimmunity Reviews},
year = {2023},
volume = {22},
number = {2},
pages = {103262},
doi = {10.1016/j.autrev.2022.103262}
}
EUVIMED